Description
Combination Products Part 1: An Industry Perspective | Combination Products technology and regulations are evolving globally. One consistent undercurrent in this dynamic regulatory environment is the drive for successful practices and control strategies throughout the combination product lifecycle. In this session we’ll discuss technical product solutions and case studies, as well as evolving global regulations from an industry perspective.
Session Leader(s):
- Susan
W. Neadle,
FAAO, FBCLA,
Sr. Director, Global Value Chain Quality Design,
Johnson & Johnson
Speaker(s):
- Jörg
Zimmermann,
Vice President, Vetter Development Service, External Affairs,
Vetter Pharma-Fertigung GmbH & Co.
- Tobias
Nemeth,
Director,
Vetter Development Services
- Mike
Wallenstein,
Novartis Global Head MDR Implementation & DD&C Compliance,
Novartis Pharma AG
- Kirsten
Paulson,
Sr. Director, Global Regulatory CMC-Medical Devices,
Pfizer, Inc.
